Form 15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-04389

 

APPLIED BIOSYSTEMS INC.

(Exact name of registrant as specified in its charter)

 

301 Merritt 7

Norwalk, Connecticut 06851

(203)-840-2000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Applera Corporation – Applied Biosystems Group Common Stock, par value $0.01 per share

Rights to Purchase Series A Participating Junior Preferred Stock, par value $0.01 per share

(Title of each class of securities covered by this Form)

 

 

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)    x    Rule 12h-3(b)(1)(i)    x
Rule 12g-4(a)(2)    ¨    Rule 12h-3(b)(1)(ii)    ¨
      Rule 15d-6    ¨

Approximate number of holders of record as of the certification or notice date:

Applera Corporation – Applied Biosystems Group Common Stock, par value $0.01 per share: None

Rights to Purchase Series A Participating Junior Preferred Stock, par value $0.01 per share: None

Pursuant to the requirements of the Securities Exchange Act of 1934, Applied Biosystems, LLC (as successor by merger to Applied Biosystems Inc.) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:  

December 8, 2008

 

By:

 

/s/ John A. Cottingham

   

Name:

 

John A. Cottingham

   

Title:

 

Chief Legal Officer and Secretary

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.